PRKAA1 and Alzheimer disease: AMPK dysfunction in AD correlates with impaired mitochondrial biogenesis and disrupted lipid metabolism, culminating in neuronal death (Assefa et al., 2020; Chew et al., 2020; Barone et al., 2021).